The present invention is directed to a compound represented by Structural Formula (1): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.
申请公布号
EP2470500(A2)
申请公布日期
2012.07.04
申请号
EP20100750214
申请日期
2010.08.27
申请人
TETRAPHASE PHARMACEUTICALS, INC.
发明人
DENG, YONGHONG;PLAMONDON, LOUIS;SUN, CUIXIANG;XIAO, XIAO-YI;ZHOU, JINGYE;SUTCLIFFE, JOYCE, A.;RONN, MAGNUS, P.
